An Iowa ingredients manufacturer has partnered with Brazilian medical cannabis company to launch several hemp-derived medical cannabis products under the brand name CBD CALM in Brazil.
Kemin Industries of Des Moines will act as the lead consultant for medical marijuana producer MedPharm Iowa, struck a deal in March with Brazilian distributor CBD Vida to deliver cannabinoid-containing products at pharmaceutical standards in Brazil, according to a Tuesday statement from Kemin Industries.
Brazil recently changed its regulations on cannabis derivatives to allow patients with a prescription to buy products containing cannabidiol directly from pharmacies. Under the regulations, which took effect March 10, the bulk import of CBD and THC products is allowed by companies that have been granted a Sanitary Authorization by the Brazilian Health Regulatory Agency (Anvisa).
According to the Kemin Industries statement, the two parties “are partnering to meet all documentation and technical requirements.”